Mainz Biomed N.V. (QUCY) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Mainz Biomed N.V. (QUCY) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $36.7M, listed on NASDAQ, employing roughly 26 people, carrying a beta of 0.43 to the broader market. Mainz Biomed NV is a molecular genetics cancer diagnostic company. Led by Guido Baechler, public since 2021-11-05.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for QUCY as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →